One-pot heterogeneous synthesis of Δ3-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB1 and CB2 receptors

European Journal of Medicinal Chemistry
2014.0

Abstract

Δ(9)-tetrahydrocannabinol (Δ(9)-THC) is the major psychoactive cannabinoid in hemp (Cannabis sativa L.) and responsible for many of the pharmacological effects mediated via cannabinoid receptors. Despite being the major cannabinoid scaffold in nature, Δ(9)-THC double bond isomers remain poorly studied. The chemical scaffold of tetrahydrocannabinol can be assembled from the condensation of distinctly substituted phenols and monoterpenes. Here we explored a microwave-assisted one pot heterogeneous synthesis of Δ(3)-THC from orcinol (1a) and pulegone (2). Four Δ(3)-THC analogues and corresponding Δ(4a)-tetrahydroxanthenes (Δ(4a)-THXs) were synthesized regioselectively and showed differential binding affinities for CB1 and CB2 cannabinoid receptors. Here we report for the first time the CB1 receptor binding of Δ(3)-THC, revealing a more potent receptor binding affinity for the (S)-(-) isomer (hCB1Ki = 5 nM) compared to the (R)-(+) isomer (hCB1Ki = 29 nM). Like Δ(9)-THC, also Δ(3)-THC analogues are partial agonists at CB receptors as indicated by [(35)S]GTPγS binding assays. Interestingly, the THC structural isomers Δ(4a)-THXs showed selective binding and partial agonism at CB2 receptors, revealing a simple non-natural natural product-derived scaffold for novel CB2 ligands.

Knowledge Graph

Similar Paper

One-pot heterogeneous synthesis of Δ3-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB1 and CB2 receptors
European Journal of Medicinal Chemistry 2014.0
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal <i>Cannabis sativa</i> Variety: Δ<sup>9</sup>-Tetrahydrocannabutol, the Butyl Homologue of Δ<sup>9</sup>-Tetrahydrocannabinol
Journal of Natural Products 2020.0
Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency<i>Cannabis sativa</i>
Journal of Natural Products 2015.0
Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoid Receptors
Journal of Medicinal Chemistry 2005.0
New Resorcinol−Anandamide “Hybrids” as Potent Cannabinoid Receptor Ligands Endowed with Antinociceptive Activity in Vivo
Journal of Medicinal Chemistry 2009.0
Carbon-silicon switch led to the discovery of novel synthetic cannabinoids with therapeutic effects in a mouse model of multiple sclerosis
European Journal of Medicinal Chemistry 2021.0
Cannabinoid Ester Constituents from High-Potency<i>Cannabis sativa</i>
Journal of Natural Products 2008.0
A 3D-QSAR Study on the Structural Requirements for Binding to CB<sub>1</sub> and CB<sub>2</sub> Cannabinoid Receptors
Journal of Medicinal Chemistry 2000.0
Novel sterically hindered cannabinoid CB1 receptor ligands
Bioorganic &amp; Medicinal Chemistry 2008.0
Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New CB<sub>2</sub>Cannabinoid Receptors Agonists:  Synthesis, Pharmacological Properties and Molecular Modeling
Journal of Medicinal Chemistry 2006.0